Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Sale of 4,000 Shares

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reported the sale of 4,000 shares of Class A Common Stock on April 11, 2024, at a price of $4.75 per share.

Summary

• On April 11, 2024, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., sold 4,000 shares of Class A Common Stock.
• The sale was executed at a price of $4.75 per share.
• The transaction was made pursuant to a standing 10b5-1 instruction adopted on April 10, 2023, to cover taxes upon the vesting of restricted stock units.
• Following the transaction, Singleton directly owns 34,665 shares of Bioventus Inc. Class A Common Stock.
• The shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $4.53 to $4.95, inclusive.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale, which is neutral in sentiment.

Industry Context

This is a routine Form 4 filing related to an insider stock sale. It is common for executives to sell shares to cover tax obligations related to vesting equity awards.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the pre-arranged nature of the sale mitigates this concern.

Key Dates